Methodology-centered review of molecular modeling, simulation, and prediction of SARS-CoV-2

K Gao, R Wang, J Chen, L Cheng, J Frishcosy… - Chemical …, 2022 - ACS Publications
Despite tremendous efforts in the past two years, our understanding of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), virus–host interactions, immune …

Potential of turmeric-derived compounds against RNA‐dependent RNA polymerase of SARS‐CoV‐2: an in-silico approach

R Singh, VK Bhardwaj, R Purohit - Computers in Biology and Medicine, 2021 - Elsevier
Abstract The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is the
causative agent of the COVID-19 pandemic. Currently, there are no particular antivirals …

How helpful were molecular dynamics simulations in shaping our understanding of SARS-CoV-2 spike protein dynamics?

JM Abduljalil, AM Elghareib, A Samir, AA Ezat… - International Journal of …, 2023 - Elsevier
The SARS-CoV-2 spike protein (S) represents an important viral component that is required
for successful viral infection in humans owing to its essential role in recognition of and entry …

Inhibition of nonstructural protein 15 of SARS‐CoV‐2 by golden spice: A computational insight

R Singh, VK Bhardwaj, R Purohit - Cell biochemistry and …, 2022 - Wiley Online Library
The quick widespread of the coronavirus and speedy upsurge in the tally of cases demand
the fast development of effective drugs. The uridine‐directed endoribonuclease activity of …

Honeysuckle (Lonicera japonica) and Huangqi (Astragalus membranaceus) Suppress SARS-CoV-2 Entry and COVID-19 Related Cytokine Storm in Vitro

YC Yeh, LH Doan, ZY Huang, LW Chu… - Frontiers in …, 2022 - frontiersin.org
COVID-19 is threatening human health worldwide but no effective treatment currently exists
for this disease. Current therapeutic strategies focus on the inhibition of viral replication or …

Identification of RdRp inhibitors against SARS-CoV-2 through E-pharmacophore-based virtual screening, molecular docking and MD simulations approaches

HM Rehman, M Sajjad, MA Ali, R Gul, M Naveed… - International Journal of …, 2023 - Elsevier
The outbreak of novel Coronavirus, an enduring pandemic declared by WHO, has
consequences to an alarming ongoing public health menace which has already claimed …

In silico analysis of SARS-CoV-2 proteins as targets for clinically available drugs

WKB Chan, KM Olson, JW Wotring, JZ Sexton… - Scientific Reports, 2022 - nature.com
The ongoing pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) requires treatments with rapid clinical translatability. Here we develop a multi-target …

A ricin-based peptide BRIP from Hordeum vulgare inhibits Mpro of SARS-CoV-2

P Kashyap, VK Bhardwaj, M Chauhan, V Chauhan… - Scientific Reports, 2022 - nature.com
COVID-19 pandemic caused by SARS-CoV-2 led to the research aiming to find the inhibitors
of this virus. Towards this world problem, an attempt was made to identify SARS-CoV-2 main …

GC-MS profiling of Bauhinia variegata major phytoconstituents with computational identification of potential lead inhibitors of SARS-CoV-2 Mpro

P More-Adate, KB Lokhande, KV Swamy… - Computers in Biology …, 2022 - Elsevier
Severe acute respiratory syndrome coronavirus 2 was originally identified in Wuhan city of
China in December 2019 and it spread rapidly throughout the globe, causing a threat to …

Comparative mutational analysis of SARS-CoV-2 isolates from Pakistan and structural-functional implications using computational modelling and simulation …

A Shah, S Rehmat, I Aslam, M Suleman… - Computers in biology …, 2022 - Elsevier
Abstract SARS-CoV-2, an RNA virus, has been prone to high mutations since its first
emergence in Wuhan, China, and throughout its spread. Its genome has been sequenced …